MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pol, O.
Right arrow Articles by Puig, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pol, O.
Right arrow Articles by Puig, M. M.

Vol. 60, Issue 5, 894-899, November 2001

Inflammation Enhances µ-Opioid Receptor Transcription and Expression in Mice Intestine

Olga Pol, Francesc Alameda, and Margarita M. Puig

Anesthesiology Research Unit, Institut Municipal Investigació Mèdica, Department of Anesthesiology, Hospital Universitario del Mar, Barcelona, Spain (O.P., M.M.P.); Department of Pathology, Hospital Universitario del Mar, Barcelona, Spain (F.A.)

Opioid receptors (ORs) and their mRNA are present in the central and peripheral nervous systems of mammals and in different peripheral tissues, including the gut. Using a model of croton oil-induced (CO) intestinal inflammation in mice, we have shown a 6-fold increase in the potency of the antitransit and antisecretory effects of µ-OR agonists, mediated by peripheral ORs. We postulate that the enhanced effects are mediated by an increase in the expression of intestinal OR. We used jejunum (stripped of the mucosal layer) from mice with CO-induced intestinal inflammation and, as control subjects, saline-treated animals (SS). We evaluated the quantity of µ-OR mRNA determined by a competitive reverse-transcriptase polymerase chain reaction; the levels of µ-OR protein by Western blot immunoassay, and the localization and number of cells expressing µ-OR using immunohistochemistry. The results show a significant increase of µ-OR mRNA (7.7-fold) and receptor protein (3-fold) during intestinal inflammation. Inflammation also induced a 64.3% increase in the number of neurons expressing µ-OR immunoreactivity in the myenteric plexus but not in the submucosal plexus. Our results show that intestinal inflammation enhances the transcription and translation of µ-OR mRNA, thus explaining the increased potency of µ-opioids during inflammation.

Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
K. T. Sykes, S. R. White, R. W. Hurley, H. Mizoguchi, L. F. Tseng, and D. L. Hammond
Mechanisms Responsible for the Enhanced Antinociceptive Effects of {micro}-Opioid Receptor Agonists in the Rostral Ventromedial Medulla of Male Rats with Persistent Inflammatory Pain
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 813 - 821.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
D. Chakass, D. Philippe, E. Erdual, S. Dharancy, M. Malapel, C. Dubuquoy, X. Thuru, J. Gay, C. Gaveriaux-Ruff, P. Dubus, et al.
{micro}-Opioid receptor activation prevents acute hepatic inflammation and cell death
Gut, July 1, 2007; 56(7): 974 - 981.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
S. Matsuzaki, M. Canis, J.-L. Pouly, R. Botchorishvili, P.J. Dechelotte, and G. Mage
Both GnRH agonist and continuous oral progestin treatments reduce the expression of the tyrosine kinase receptor B and mu-opioid receptor in deep infiltrating endometriosis
Hum. Reprod., January 1, 2007; 22(1): 124 - 128.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
N. Jimenez, M. M. Puig, and O. Pol
Antiexudative Effects of Opioids and Expression of {kappa}- and {delta}- Opioid Receptors during Intestinal Inflammation in Mice: Involvement of Nitric Oxide
J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 261 - 270.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
E. S. Kimball, J. M. Palmer, M. R. D'Andrea, P. J. Hornby, and P. R. Wade
Acute colitis induction by oil of mustard results in later development of an IBS-like accelerated upper GI transit in mice
Am J Physiol Gastrointest Liver Physiol, June 1, 2005; 288(6): G1266 - G1273.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
C. Borner, J. Kraus, H. Schroder, H. Ammer, and V. Hollt
Transcriptional Regulation of the Human {micro}-Opioid Receptor Gene by Interleukin-6
Mol. Pharmacol., December 1, 2004; 66(6): 1719 - 1726.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
S. Matsuzaki, M. Canis, C. Vaurs-Barriere, J.L. Pouly, O. Boespflug-Tanguy, F. Penault-Llorca, P. Dechelotte, B. Dastugue, K. Okamura, and G. Mage
DNA microarray analysis of gene expression profiles in deep endometriosis using laser capture microdissection
Mol. Hum. Reprod., October 1, 2004; 10(10): 719 - 728.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
J. Kraus, C. Borner, E. Giannini, and V. Hollt
The Role of Nuclear Factor {kappa}B in Tumor Necrosis Factor-Regulated Transcription of the Human {micro}-Opioid Receptor Gene
Mol. Pharmacol., October 1, 2003; 64(4): 876 - 884.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
O. Pol, J. R. Palacio, and M. M. Puig
The Expression of {delta}- and {kappa}-Opioid Receptor Is Enhanced during Intestinal Inflammation in Mice
J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 455 - 462.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics